• No results found

Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration Grauss, R.W.

N/A
N/A
Protected

Academic year: 2021

Share "Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration Grauss, R.W."

Copied!
8
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Citation

Grauss, R. W. (2008, January 17). Regenerative medicine in cardiovascular disease: from tissue enginering to tissue regeneration. Retrieved from https://hdl.handle.net/1887/12556

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12556

Note: To cite this publication please use the final published version (if

applicable).

(2)

Colophon

The studies described in this thesis were performed at the departments of Antomy and Embryology, and Cardiology of the Leiden University Medical Center, Leiden, the Netherlands.

Copyright © 2008 Robert W. Grauss, Leiden, the Netherlands. All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, whitout prior written permission of the author.

Cover After a painting by Mieneke van Teylingen

“Salamanders are the superstars of regeneration. They can grow back not only limbs but also tails, parts of their hearts and the retinas and lenses in their eyes.” New York Times, September 24, 2002

Layout De Boer & van Teylingen, The Hague, the Netherlands Printed by Den Haag Off set, The Hague, the Netherlands ISBN 978-90-9022595-1

R E G E N E R A T I V E M E D I C I N E I N C A R D I O V A S C U L A R D I S E A S E : F R O M T I S S U E E N G I N E E R I N G T O T I S S U E R E G E N E R A T I O N

(3)

PROEFSCHRIFT ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnifi cus prof. mr. P. F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 17 januari 2008

klokke 13.45 uur

door

ROBERT WILLEM GR AUSS geboren te Oud Beijerland

in 1977

(4)

PROMOTIECOMMISSIE

P R O M O T O R E S PROF. DR. M .J. SCHALIJ

PROF. DR. A .C. GITTENBERGER-DE GROOT

C O - P R O M O T O R E S DR. D.E. ATSMA DR. M .C. DE RUITER

R E F E R E N T PROF. DR. D.J. VAN VELDHUISEN

(UNIVERSITEIT VAN GRONINGEN)

L I D PROF. DR. W.E. FIBBE

Financial support by the Netherlands Heart Foundation for the publication of this thesis is gratefully acknowledged.

R E G E N E R A T I V E M E D I C I N E I N C A R D I O V A S C U L A R D I S E A S E : F R O M T I S S U E E N G I N E E R I N G T O T I S S U E R E G E N E R A T I O N

(5)

“THIS IS NOT THE END. IT IS NOT EVEN THE BEGINNING OF THE END.

BUT IT IS, PERHAPS, THE END OF THE BEGINNING”

Sir Winston Churchill (1942)

Voor mijn ouders Aan Carolien

(6)

TABLE OF CONTENTS

Chapter 1 General introduction and outline of the thesis 9

P A R T I T I S S U E E N G I N E E R I N G O F A O R T I C V A L V E L E A F L E T S 47

Chapter 2 Histological evaluation of decellularised porcine aortic valves:

matrix changes due to diff erent decellularisation methods

Eur J Cardiothorac Surg. 2005;27:566-71 49

Chapter 3 Decellularisation of rat aortic valve allografts reduces leafl et destruction and extracellular matrix remodeling

J Thoracic Cardiovasc Surg 2003;126:2003-10 63 Letter to the editor

J Thoracic Cardiovasc Surg 2004;128:155-56 80

Chapter 4 Decellularization of rat aortic valve allografts reduces the cellular immune response resulting in a structurally intact collagen network irrespective of collagen denaturation

Submitted for publication 83

P A R T I I C E L L B A S E D R E G E N E R A T I V E T H E R A P Y F O R T H E T R E A T M E N T O F

A C U T E M Y O C A R D I A L I N F A R C T I O N 101

Chapter 5 Mesenchymal Stem Cells from Ischemic Heart Disease Patients Improve Left Ventricular Function after Myocardial Infarction

Am J Physiol Heart Circ Physiol 2007;293:H2438-47 103

Chapter 6 Forced Myocardin Expression enhances the therapeutic eff ect of Mesenchymal Stem Cells from Patients with Ischemic Heart Disease in a Mouse Myocardial Infarction Model

Submitted for publication 123

Chapter 7 Preservation of left ventricular function and attenuation of remodelling after transplantation of human epicardium-derived cells into the infarcted mouse heart

Circulation 2007;116:917-27 145

R E G E N E R A T I V E M E D I C I N E I N C A R D I O V A S C U L A R D I S E A S E : F R O M T I S S U E E N G I N E E R I N G T O T I S S U E R E G E N E R A T I O N

(7)

P A R T I I I C A R D I A C P H E N O T Y P I N G I N R E G E N E R A T I V E M E D I C I N E : D I F F E R E N T

M E T H O D S F O R T H E M U R I N E H E A R T 177

Chapter 8 Assessment of left ventricular function in the chronic ischemic failing mouse heart by magnetic resonance imaging and conductance catheter: a head to head comparison

Submitted for publication 179

S U M M A R Y , C O N C L U S I O N S A N D F U T U R E P E R S P E C T I V E S 197

S A M E N V A T T I N G , C O N C L U S I E S E N T O E K O M S T P E R S P E C T I E V E N 205

L I S T O F P U B L I C A T I O N S 215

A C K N O W L E D G E M E N T S 220

C U R R I C U L U M V I T A E 223

(8)

8

R E G E N E R A T I V E M E D I C I N E I N C A R D I O V A S C U L A R D I S E A S E : F R O M T I S S U E E N G I N E E R I N G T O T I S S U E R E G E N E R A T I O N

Referenties

GERELATEERDE DOCUMENTEN

The authors of “Decellularization of rat aortic valve allografts reduces leafl et destruction and extracellular matrix remodeling”, have elegantly evaluated various methods

In a rat aortic valve transplantation model [7] transplantation of decellularised AVA between MHC-mismatched rats, valves were still morphologically intact after 3 weeks, whereas

Key fi ndings of the present study are that in an immune-compromised mouse model of acute MI, intra-myocardial injection of hMSCs from patients with IHD resulted in (i) a signifi

Key fi ndings of this study are: (1) Injection of hMSC and hMSC myoc into infarcted myocardium results in a relatively preserved LV function compared to injection of medium alone;

It seems unlikely that new cardiomyocyte formation [40] contributed to the increment in wall thickness in the hEPDC-group, since the cardiomyocytes observed in the subendocardial

Figure 4: Schematic pressure-volume loops (based on mean end-diastolic and end-systolic pressures and volumes) obtained by conduct- ance catheter in sham-operated mice without

• Mesenchymal stem cells from patients with ischemic heart disease can engraft in the inf- arcted mouse myocardium and preserve LV function 2 weeks after acute myocardial infarction,

In Hoofdstuk 5 hebben we de haalbaarheid van het gebruik van humane mesenchymale stam- cellen (hMSC) uit patiënten met ischemische hartziekten (IHD) als celtherapie voor het acute